{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T10:54:56Z","timestamp":1760266496779},"reference-count":32,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2004,7,21]],"date-time":"2004-07-21T00:00:00Z","timestamp":1090368000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Aliment Pharmacol Ther"],"published-print":{"date-parts":[[2004,8]]},"abstract":"<jats:title>Summary<\/jats:title><jats:p><jats:bold>Background<\/jats:bold> :\u2002The presence of the gastric pathogen, <jats:italic>Helicobacter pylori<\/jats:italic> influences acid suppression by proton pump inhibitors and treatment outcome in patients with gastro\u2010oesophageal reflux disease.<\/jats:p><jats:p><jats:bold>Aim<\/jats:bold> :\u2002To determine the influence of <jats:italic>H. pylori<\/jats:italic> infection on effectiveness of rabeprazole in primary and secondary care patients with gastro\u2010oesophageal reflux disease.<\/jats:p><jats:p><jats:bold>Methods<\/jats:bold> :\u2002Patients from primary and secondary care centres with uninvestigated gastro\u2010oesophageal reflux disease (based on symptoms only) and investigated gastro\u2010oesophageal reflux disease (endoscopically confirmed oesophagitis or endoscopy\u2010negative reflux disease) were tested for <jats:italic>H. pylori<\/jats:italic> and treated with rabeprazole 20\u2003mg once daily for 4\u20138\u2003weeks in a non\u2010randomized, multicentre, open\u2010label study. Primary end\u2010point for treatment effectiveness was complete resolution of both heartburn and acid regurgitation at 4\u20138\u2003weeks; secondary end\u2010point was quality of life as registered with the Psychological General Well\u2010being Index.<\/jats:p><jats:p><jats:bold>Results<\/jats:bold> :\u2002Data of 1787 patients could be analysed; mean duration of treatment was 36.3\u2003days. At the evaluation visit 76.9% were heartburn\u2010free, 77.7% regurgitation\u2010free and 71% had complete symptom resolution. Overall Psychological General Well\u2010being Index scores improved accordingly. Treatment was equally effective in patients with or without <jats:italic>H. pylori<\/jats:italic> infection, but more effective in patients with oesophagitis when compared with symptomatic gastro\u2010oesophageal reflux disease.<\/jats:p><jats:p><jats:bold>Conclusions<\/jats:bold> :\u2002The effectiveness of rabeprazole in gastro\u2010oesophageal reflux disease is not affected by the presence of <jats:italic>H. pylori<\/jats:italic> infection.<\/jats:p>","DOI":"10.1111\/j.1365-2036.2004.02096.x","type":"journal-article","created":{"date-parts":[[2004,8,5]],"date-time":"2004-08-05T15:23:16Z","timestamp":1091719396000},"page":"451-458","source":"Crossref","is-referenced-by-count":9,"title":["Treatment of gastro\u2010oesophageal reflux disease with rabeprazole in primary and secondary care: does <scp>Helicobacter pylori<\/scp> infection affect proton pump inhibitor effectiveness?"],"prefix":"10.1111","volume":"20","author":[{"given":"N. J.","family":"de Wit","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W. A.","family":"de Boer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Geldof","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Hazelhoff","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Bergmans","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G. N. J.","family":"Tytgat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A. J. P. M.","family":"Smout","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2004,7,21]]},"reference":[{"key":"e_1_2_19_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9343(99)00347-2"},{"key":"e_1_2_19_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0016-5085(97)70025-8"},{"key":"e_1_2_19_4_2","doi-asserted-by":"publisher","DOI":"10.3109\/00365529108996486"},{"key":"e_1_2_19_5_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.2000.00884.x"},{"key":"e_1_2_19_6_2","doi-asserted-by":"publisher","DOI":"10.3109\/00365529509090292"},{"key":"e_1_2_19_7_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.322.7282.344"},{"key":"e_1_2_19_8_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1525-1497.2003.20833.x"},{"key":"e_1_2_19_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0149-2918(00)80032-6"},{"key":"e_1_2_19_10_2","first-page":"478","article-title":"Prevalence of Helicobacter pylori infection and dyspepsia in young adults in Germany","volume":"34","author":"Glasbrenner B","year":"1996","journal-title":"Z Gastroenterol"},{"key":"e_1_2_19_11_2","doi-asserted-by":"publisher","DOI":"10.1093\/fampra\/17.suppl_2.S27"},{"key":"e_1_2_19_12_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.326.7392.737"},{"key":"e_1_2_19_13_2","doi-asserted-by":"publisher","DOI":"10.1097\/00042737-200106000-00026"},{"key":"e_1_2_19_14_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.2000.00677.x"},{"key":"e_1_2_19_15_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0016-5085(97)70024-6"},{"key":"e_1_2_19_16_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.1999.00535.x"},{"key":"e_1_2_19_17_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.2003.01488.x"},{"key":"e_1_2_19_18_2","doi-asserted-by":"publisher","DOI":"10.1136\/gut.36.4.539"},{"key":"e_1_2_19_19_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.1999.00531.x"},{"key":"e_1_2_19_20_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0016-5085(99)70544-5"},{"key":"e_1_2_19_21_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.319.7209.550"},{"key":"e_1_2_19_22_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.1999.982_e.x"},{"key":"e_1_2_19_23_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.1997.00246.x"},{"key":"e_1_2_19_24_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(00)04894-7"},{"key":"e_1_2_19_25_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.2003.01549.x"},{"key":"e_1_2_19_26_2","doi-asserted-by":"crossref","first-page":"4150","DOI":"10.1128\/JCM.37.12.4150-4152.1999","article-title":"Evaluation of three commercial serological tests with different methodologies to assess Helicobacter pylori infection","volume":"37","author":"Van der Ende A","year":"1999","journal-title":"J Clin Microbiol"},{"key":"e_1_2_19_27_2","first-page":"170","volume-title":"Assessment of Quality of Life in Clinical Trials of Cardiovascular Therapies","author":"Dupuy HJ.","year":"1984"},{"key":"e_1_2_19_28_2","doi-asserted-by":"publisher","DOI":"10.3109\/00365529609095544"},{"key":"e_1_2_19_29_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2003.07158.x"},{"key":"e_1_2_19_30_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.1998.00399.x"},{"key":"e_1_2_19_31_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2002.07026.x"},{"key":"e_1_2_19_32_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.2002.01181.x"},{"key":"e_1_2_19_33_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1590-8658(01)80100-6"}],"container-title":["Alimentary Pharmacology &amp; Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2036.2004.02096.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2036.2004.02096.x","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1365-2036.2004.02096.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,13]],"date-time":"2023-10-13T21:22:08Z","timestamp":1697232128000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2036.2004.02096.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,7,21]]},"references-count":32,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2004,8]]}},"alternative-id":["10.1111\/j.1365-2036.2004.02096.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1365-2036.2004.02096.x","archive":["Portico"],"relation":{},"ISSN":["0269-2813","1365-2036"],"issn-type":[{"value":"0269-2813","type":"print"},{"value":"1365-2036","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,7,21]]}}}